These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
596 related articles for article (PubMed ID: 1346255)
1. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Fults D; Brockmeyer D; Tullous MW; Pedone CA; Cawthon RM Cancer Res; 1992 Feb; 52(3):674-9. PubMed ID: 1346255 [TBL] [Abstract][Full Text] [Related]
2. Chromosome 10 and 17 deletions and p53 gene mutations in Thai patients with astrocytomas. Put-Ti-Noi S; Petmitr S; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W Oncol Rep; 2004 Jan; 11(1):207-11. PubMed ID: 14654927 [TBL] [Abstract][Full Text] [Related]
3. p53 mutation, EGFR gene amplification and loss of heterozygosity on chromosome 10, 17 p in human gliomas. Jin W; Xu X; Yang T; Hua Z Chin Med J (Engl); 2000 Jul; 113(7):662-6. PubMed ID: 11776043 [TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumours. Chattopadhyay P; Rathore A; Mathur M; Sarkar C; Mahapatra AK; Sinha S Oncogene; 1997 Aug; 15(7):871-4. PubMed ID: 9266974 [TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity for loci on chromosome 17p in human malignant astrocytoma. Fults D; Tippets RH; Thomas GA; Nakamura Y; White R Cancer Res; 1989 Dec; 49(23):6572-7. PubMed ID: 2573417 [TBL] [Abstract][Full Text] [Related]
6. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies. Watanabe K; Sato K; Biernat W; Tachibana O; von Ammon K; Ogata N; Yonekawa Y; Kleihues P; Ohgaki H Clin Cancer Res; 1997 Apr; 3(4):523-30. PubMed ID: 9815715 [TBL] [Abstract][Full Text] [Related]
7. Allelotype of human malignant astrocytoma. Fults D; Pedone CA; Thomas GA; White R Cancer Res; 1990 Sep; 50(18):5784-9. PubMed ID: 1975510 [TBL] [Abstract][Full Text] [Related]
8. Somatic mutations of PTEN in glioblastoma multiforme. Wang SI; Puc J; Li J; Bruce JN; Cairns P; Sidransky D; Parsons R Cancer Res; 1997 Oct; 57(19):4183-6. PubMed ID: 9331071 [TBL] [Abstract][Full Text] [Related]
9. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179 [TBL] [Abstract][Full Text] [Related]
11. Detection of a novel point mutation in the p53 gene in grade II astrocytomas by PCR-SSCP analysis with additional Klenow treatment. Chawengchao B; Petmitr S; Ponglikitmongkol M; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W Anticancer Res; 2001; 21(4A):2739-43. PubMed ID: 11724349 [TBL] [Abstract][Full Text] [Related]
12. Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products. Mashiyama S; Murakami Y; Yoshimoto T; Sekiya T; Hayashi K Oncogene; 1991 Aug; 6(8):1313-8. PubMed ID: 1886708 [TBL] [Abstract][Full Text] [Related]
13. Identification of a human homolog of the Drosophila neuralized gene within the 10q25.1 malignant astrocytoma deletion region. Nakamura H; Yoshida M; Tsuiki H; Ito K; Ueno M; Nakao M; Oka K; Tada M; Kochi M; Kuratsu J; Ushio Y; Saya H Oncogene; 1998 Feb; 16(8):1009-19. PubMed ID: 9519875 [TBL] [Abstract][Full Text] [Related]
14. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas. Lang FF; Miller DC; Pisharody S; Koslow M; Newcomb EW Oncogene; 1994 Mar; 9(3):949-54. PubMed ID: 8108140 [TBL] [Abstract][Full Text] [Related]
15. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. von Deimling A; Eibl RH; Ohgaki H; Louis DN; von Ammon K; Petersen I; Kleihues P; Chung RY; Wiestler OD; Seizinger BR Cancer Res; 1992 May; 52(10):2987-90. PubMed ID: 1349850 [TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of areas with low grade tumor or satellitosis in human malignant astrocytomas. Leenstra S; Troost D; Westerveld A; Bosch DA; Hulsebos TJ Cancer Res; 1992 Mar; 52(6):1568-72. PubMed ID: 1311634 [TBL] [Abstract][Full Text] [Related]
18. Mutations in the p53 gene in human astrocytomas: detection by single-strand conformation polymorphism analysis and direct DNA sequencing. Hunter SB; Bandea C; Swan D; Abbott K; Varma VA Mod Pathol; 1993 Jul; 6(4):442-5. PubMed ID: 8415589 [TBL] [Abstract][Full Text] [Related]
19. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency. Frankel RH; Bayona W; Koslow M; Newcomb EW Cancer Res; 1992 Mar; 52(6):1427-33. PubMed ID: 1347252 [TBL] [Abstract][Full Text] [Related]
20. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors. Lang FF; Miller DC; Koslow M; Newcomb EW J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]